STOCK TITAN

Cerence (NASDAQ: CRNC) director Marcy Klevorn to step down from board

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Cerence Inc. reported that director Marcy Klevorn has decided to resign from its Board of Directors, effective July 1, 2026. The company states that her resignation is for personal reasons and not due to any disagreement regarding operations, policies, practices, accounting, or financial statements. Klevorn served on the Board’s Compensation Committee and Nominating and Governance Committee. Cerence publicly thanked her for her contributions and service during her tenure.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Notification date June 28, 2026 Date Marcy Klevorn informed Cerence Board of resignation
Effective resignation date July 1, 2026 Date Marcy Klevorn’s resignation from Cerence Board takes effect
Emerging growth company regulatory
"Emerging growth company o"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Compensation Committee financial
"served as a member of the Compensation Committee and the Nominating"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
Nominating and Governance Committee financial
"Compensation Committee and the Nominating and Governance Committee of the Board"
A nominating and governance committee is a group of board members tasked with choosing and evaluating directors, planning leadership succession, and setting the company’s board-related rules and ethical standards. Think of it as the company’s hiring and rule-making panel for its top overseers. Its work matters to investors because it shapes who governs the company, how leadership transitions are handled, and whether the board can effectively oversee management and protect shareholder interests.
Section 12(b) regulatory
"Securities registered pursuant to Section 12(b) of the Act"
Section 12(b) of the U.S. Securities Exchange Act requires securities listed on a national stock exchange to be registered with the U.S. Securities and Exchange Commission (SEC) and to follow regular public reporting and disclosure rules. For investors, a 12(b) listing generally means more routine financial updates, regulatory oversight and easier buying and selling—like a storefront that must display its inventory and prices, making it simpler to inspect and trade the product.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
0001768267FALSE00017682672026-06-282026-06-28

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________________________________________
FORM 8-K
________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 28, 2026
________________________________________________________
CERENCE INC.
(Exact name of Registrant as Specified in Its Charter)
________________________________________________________
Delaware001-3903083-4177087
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)(IRS Employer
Identification No.)
1500 District Avenue,
Burlington, Massachusetts
01803
(Address of Principal Executive Offices)(Zip Code)
Registrant’s Telephone Number, Including Area Code: (857)362-7300
25 Mall Road, Suite 416, Burlington, Massachusetts
(Former Name or Former Address, if Changed Since Last Report)
________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading
Symbol(s)
Name of each exchange on which registered
Common stock, $0.01 par valueCRNCThe NASDAQ Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 28, 2026, Marcy Klevorn notified the Board of Directors (the "Board") of Cerence Inc. (the "Company") of her decision to resign from the Board, effective July 1, 2026. Ms. Klevorn's resignation was for personal reasons and was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices, including any matter relating to the Company's accounting practices or financial statements.
At the time of her resignation, Ms. Klevorn served as a member of the Compensation Committee and the Nominating and Governance Committee of the Board.
The Company thanks Ms. Klevorn for her valuable contributions and dedicated service to the Company and its Board of Directors during her tenure.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Cerence Inc.
Date: July 2, 2026
By:/s/ Brian Krzanich
Name: Brian Krzanich
Title: President, Chief Executive Officer

FAQ

What did Cerence Inc. (CRNC) disclose in this 8-K filing?

Cerence Inc. disclosed that board member Marcy Klevorn has decided to resign from the Board, effective July 1, 2026. The company notes the decision is for personal reasons and not related to disagreements over operations, policies, practices, accounting, or financial statements.

When is Cerence director Marcy Klevorn’s resignation effective?

Marcy Klevorn’s resignation from the Cerence Inc. Board of Directors is effective July 1, 2026. She notified the Board of her decision on June 28, 2026, providing a short transition period before her departure from governance responsibilities at the company.

Why did Marcy Klevorn resign from Cerence Inc.’s Board of Directors?

Cerence Inc. states that Marcy Klevorn resigned from its Board for personal reasons. The filing explicitly notes that her decision was not due to any disagreement with the company on operations, policies, practices, accounting matters, or financial statements, limiting concern about underlying conflicts.

Which Cerence Inc. board committees did Marcy Klevorn serve on?

At the time of her resignation, Marcy Klevorn served on Cerence Inc.’s Compensation Committee and the Nominating and Governance Committee. Her departure therefore affects two key governance bodies overseeing executive pay and director nominations at the company.

Who signed the Cerence Inc. 8-K reporting Marcy Klevorn’s resignation?

The 8-K was signed on behalf of Cerence Inc. by Brian Krzanich, who is identified as the company’s President and Chief Executive Officer. His signature indicates the filing is an authorized disclosure under the Securities Exchange Act of 1934 requirements.

Filing Exhibits & Attachments

3 documents